Statin utilization and determinants of prescribing among people living with HIV in a Canadian tertiary care cohort
People living with HIV (PLWH) have increased risk of atherosclerotic cardiovascular disease (ASCVD), even with sustained viral suppression. Persistent immune activation and chronic inflammation contribute to this risk and may be favourably modified by statins beyond lipid lowering. However, Canadian real-world stat...